Skip to main content
. Author manuscript; available in PMC: 2023 Apr 29.
Published in final edited form as: Int Rev Immunol. 2022 Apr 29;41(6):638–648. doi: 10.1080/08830185.2022.2067154

Table 1:

Potential benefits of using automated closed-system technology for T cell manufacturing

• Ability to maintain sterility via functionally closed disposables
• Reduce operator errors by relying on pre-programmed steps
• Increased consistency by reducing operator-to-operator variability
• Reduce hands-on time for technicians, which may reduce product cost
• Less skilled workforce required; potential cost savings in training staff